Kestra Medical Technologies Signals Profitable Growth Path
TipRanks (Tue, 15-Sep 8:33 PM ET)
Analysts Are Bullish on Top NA Stocks: Kestra Medical Technologies Ltd. (KMTS), Humana (HUM)
TipRanks (Tue, 15-Sep 7:30 AM ET)
TipRanks (Tue, 15-Sep 7:15 AM ET)
At a glance: stocks gapping down premarket
Seeking Alpha News (Tue, 15-Sep 6:57 AM ET)
Stifel Nicolaus Keeps Their Buy Rating on Kestra Medical Technologies Ltd. (KMTS)
TipRanks (Tue, 15-Sep 6:46 AM ET)
TipRanks (Tue, 15-Sep 6:45 AM ET)
Seeking Alpha News (Mon, 14-Sep 4:05 PM ET)
Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results
Globe Newswire (Mon, 14-Sep 4:01 PM ET)
Kestra Names Daniel Finney Vice President of Research & Development
Globe Newswire (Thu, 10-Sep 6:00 AM ET)
Kestra Medical Technologies to Report First Quarter Fiscal 2027 Financial Results on September 14
Globe Newswire (Mon, 31-Aug 4:01 PM ET)
Kestra Medical Technologies Ltd is a commercial-stage wearable medical device and digital healthcare company focused on connected monitoring, therapeutic intervention, and data-driven clinical insights for cardiovascular disease. It has developed and is commercializing the Cardiac Recovery System platform, an integrated cardiac recovery ecosystem designed to support patients at elevated risk of sudden cardiac arrest (SCA) during vulnerable periods of recovery. The platform is anchored by the ASSURE Wearable Cardioverter Defibrillator (WCD), which continuously monitors patient heart rhythms and automatically delivers defibrillation therapy when life-threatening ventricular arrhythmias are detected. The platform also includes digital patient engagement and clinical workflow solutions.
Kestra Medical Techs trades on the NASDAQ stock market under the symbol KMTS.
As of September 16, 2026, KMTS stock price declined to $24.08 with 821,940 million shares trading.
KMTS has a beta of 1.77, meaning it tends to be more sensitive to market movements. KMTS has a correlation of 0.10 to the broad based SPY ETF.
KMTS has a market cap of $1.43 billion. This is considered a Small Cap stock.
Last quarter Kestra Medical Techs reported $31 million in Revenue and -$.75 earnings per share. This beat revenue expectation by $2 million and missed earnings estimates by -$.13.
The top ETF exchange traded funds that KMTS belongs to (by Net Assets): VTI, IWM, IWO, VXF, FYC.
KMTS has underperformed the market in the last year with a price return of +3.8% while the SPY ETF gained +15.4%. However, in the short term, KMTS had mixed performance relative to the market. It has outperformed in the last 3 months, returning +25.2% vs +0.7% return in SPY. But in the last 2 weeks, KMTS shares have been beat by the market, returning -6.4% compared to an SPY return of -1.5%.
KMTS support price is $24.29 and resistance is $26.08 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that KMTS shares will trade within this expected range on the day.